BERLDRGPharmaceuticals
Beryl Drugs Ltd — PE Ratio & Valuation Analysis
₹19.28
-9.36%
Current P/E50.15xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E23.8x110.7% above avg
⚠️
57.9% Premium to Industry
BERLDRG P/E 50.15x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹1.52 | ₹36 | 23.8x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Beryl Drugs Ltd Valuation
Beryl Drugs Ltd (BERLDRG) currently trades at 50.15x earnings. The Pharmaceuticals sector average PE is 31.77x. BERLDRG commands a premium, reflecting high growth expectations. Historically, BERLDRG has traded at an average PE of 23.8x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
6.30%
Dividend Yield
0.00%
More on Beryl Drugs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.